Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
MUSTGROW BIOLOGICS CORP. |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 1.060 CAD | -2.75% | -7.83% | -70.06% | |
| Sales 2023 * | - | Sales 2024 * | - | Capitalization | 53.08 M 39.17 M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | - |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 * | -11,8x | P/E ratio 2024 * | Employees | - | |
| Yield 2023 * | - | Yield 2024 * |
-
| Free-Float | 91.49% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.75% | ||
| 1 week | -7.83% | ||
| 1 month | -24.29% | ||
| 3 months | -31.17% | ||
| 6 months | -50.47% | ||
| Current year | -70.06% |
1 week
1.06
1.26
1 month
1.051.49
Current year
0.723.95
1 year
0.723.95
3 years
0.705.60
5 years
0.255.60
10 years
0.255.60
| Managers | Title | Age | Since |
|---|---|---|---|
Corey Giasson
CEO | Chief Executive Officer | 45 | 2018 |
Todd Lahti
DFI | Director of Finance/CFO | 57 | 2018 |
Colin Bletsky
COO | Chief Operating Officer | 48 | 2018 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Brian Quigley
BRD | Director/Board Member | 49 | 2019 |
Brad Munro
CHM | Chairman | 63 | 2018 |
Corey Giasson
CEO | Chief Executive Officer | 45 | 2018 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-30 | 1.060 | -2.75% | 12,784 |
| 23-11-29 | 1.090 | -6.84% | 18,900 |
| 23-11-28 | 1.170 | +6.36% | 16,900 |
| 23-11-27 | 1.100 | -4.35% | 7,963 |
| 23-11-24 | 1.150 | -.--% | 924 |
Delayed Quote Bourse de Toronto, November 30, 2023 at 02:44 pm EST
More quotes
MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company focused on providing science-based biological solutions for high-value crops. The Company is engaged in developing organic biocontrol, soil amendment and bio fertility products by harnessing the natural defense mechanism and organic materials of the mustard plant to sustainably protect the global food supply. It focuses on the development and commercialization of natural biological technologies and products from mustard seed for sustainable agricultural markets. The Company is providing a natural, organic technology platform with the efficacy of synthetic chemicals that has potential application in multiple global markets. Its technology pipeline includes soil amendment & bio fertility, biocontrol, and postharvest biocontrol & food preservation. The Company is pursuing the adoption and use of its technology in the soil amendment and bio fertility markets.
Calendar
2024-04-24
- Q4 2023 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.060
Average target price
-
Spread / Average Target
-100.00%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -70.06% | 40 M $ | |
| +65.91% | 40 283 M $ | |
| +4.50% | 39 020 M $ | |
| -56.74% | 30 125 M $ | |
| -25.31% | 28 999 M $ | |
| +37.42% | 21 980 M $ | |
| -29.20% | 20 582 M $ | |
| +1.50% | 17 372 M $ | |
| -13.70% | 10 906 M $ | |
| -9.55% | 10 111 M $ |
